What the science supports
SGLT1 couples sodium and glucose uptake in the small intestine. That established physiology is the rationale for including both in the planned BIOS BASE formula.
Back to the science
Evidence & validation
The biology is established. The product evidence must be earned.
BIOS BASE is a consumer hydration supplement formulated with sodium and glucose as a near-equimolar serving input. Sodium-glucose cotransport is a well-characterized intestinal mechanism; however, BIOS has not completed a product-specific human study or a head-to-head comparison.
What we do not claim
We do not claim that BIOS hydrates faster, outperforms another product, treats dehydration, or produces a particular clinical outcome without product-specific evidence.
How the formula is described
The disclosed BIOS BASE serving contains 255 mg sodium and 2 g glucose—about 11.1 mmol of each. The serving ratio is a formulation choice, not a claim that it recreates SGLT1’s 2:1 membrane stoichiometry.
Proof plan
What BIOS will validate before stronger claims.
1
Formula & label reconciliation
Confirm final ingredients, elemental mineral amounts, serving instructions, and product classification before launch.
2
Independent lot testing
Retain third-party certificates of analysis and appropriate potency, contaminant, and microbiological results for each launch lot.
3
Beverage characterization
Measure finished-product osmolality, pH, solubility, and stability at the exact 12 oz, 16 oz, and 20 oz mixing directions.
4
Consumer-use learning
Use a documented sensory and tolerance pilot to understand mixability, preference, and real-world use before broader claims are considered.
5
Claim-by-claim review
Make only statements that match the finished formula, supporting evidence, intended audience, and approved label language.
Clear boundaries protect customers and the mission.
BIOS is not an oral rehydration solution and is not intended to diagnose, treat, cure, or prevent disease. WHO oral rehydration salts serve a clinical purpose; their scientific context does not make BIOS a medical treatment. Before launch, BIOS will maintain final formula records, quality documentation, lot-release specifications, a complaint process, and counsel-reviewed claims language.
These statements have not been evaluated by the Food and Drug Administration. BIOS products are dietary supplements and are not intended to diagnose, treat, cure, or prevent any disease.